1. Home
  2. TECX vs DDD Comparison

TECX vs DDD Comparison

Compare TECX & DDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$19.98

Market Cap

366.8M

Sector

N/A

ML Signal

HOLD

Logo 3D Systems Corporation

DDD

3D Systems Corporation

HOLD

Current Price

$2.21

Market Cap

373.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
DDD
Founded
2019
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
366.8M
373.9M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
DDD
Price
$19.98
$2.21
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$80.40
$4.75
AVG Volume (30 Days)
225.8K
5.3M
Earning Date
03-19-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.10
Revenue
N/A
$391,651,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.31
P/E Ratio
N/A
$21.39
Revenue Growth
N/A
N/A
52 Week Low
$13.70
$1.32
52 Week High
$61.07
$5.00

Technical Indicators

Market Signals
Indicator
TECX
DDD
Relative Strength Index (RSI) 50.53 45.82
Support Level $18.78 $2.47
Resistance Level $20.66 $2.89
Average True Range (ATR) 1.26 0.20
MACD 0.06 -0.04
Stochastic Oscillator 65.50 4.86

Price Performance

Historical Comparison
TECX
DDD

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About DDD 3D Systems Corporation

3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.

Share on Social Networks: